Attached files
| file | filename |
|---|---|
| EX-10.5 - EXHIBIT 10.5 - Cardiovascular Systems Inc | ex105-fy18execincentiveplan.htm |
| 10-K - 10-K - Cardiovascular Systems Inc | csii10-kx63017.htm |
| EX-32.2 - EXHIBIT 32.2 - Cardiovascular Systems Inc | ex322-63017.htm |
| EX-32.1 - EXHIBIT 32.1 - Cardiovascular Systems Inc | ex321-63017.htm |
| EX-31.2 - EXHIBIT 31.2 - Cardiovascular Systems Inc | ex312-63017.htm |
| EX-31.1 - EXHIBIT 31.1 - Cardiovascular Systems Inc | ex311-63017.htm |
| EX-10.58 - EXHIBIT 10.58 - Cardiovascular Systems Inc | ex1058-koehnseparationagre.htm |
| EX-10.57 - EXHIBIT 10.57 - Cardiovascular Systems Inc | ex1057-healthtrustamendment.htm |
| EX-10.46 - EXHIBIT 10.46 - Cardiovascular Systems Inc | ex1046-2014planperformance.htm |
| EX-10.6 - EXHIBIT 10.6 - Cardiovascular Systems Inc | ex106-fy18directorcomp.htm |
| EX-10.4 - EXHIBIT 10.4 - Cardiovascular Systems Inc | ex104-fy18basesalaries.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-158755, 333-160609, 333-168682, 333-175703, 333-182668, 333-189856, 333-197348, 333-200214, and 333-208137) of Cardiovascular Systems, Inc. of our report dated August 24, 2017 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Minneapolis, Minnesota
August 24, 2017